Skip to Main Content

Author Details

Aleena Banerji
Massachusetts General Hospital, Mass Harvard Medical School
2005
179
44
PMIDPaper TitleJournal TitlePublished Year
37951415Improving care using outpatient electronic consults in patients with chemotherapy hypersensitivity reactions.J Allergy Clin Immunol Pract2024
36108922Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.J Allergy Clin Immunol Pract2023
37557950Drug allergy in older adults: A study from the United States Drug Allergy Registry.Ann Allergy Asthma Immunol2023
37652140United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions.J Allergy Clin Immunol2023
35842747Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry.Allergy2023
37150547Delayed Intradermal Skin Testing to Diagnose Culprits Drugs in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS).J Allergy Clin Immunol Pract2023
37248521A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis.Allergy Asthma Clin Immunol2023
37116793Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape.J Allergy Clin Immunol Pract2023
37295474Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.J Allergy Clin Immunol2023
37328263Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.Allergy Asthma Proc2023
37028510Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema.Ann Allergy Asthma Immunol2023
36581074Urticaria after COVID-19 vaccination and vaccine hesitancy.J Allergy Clin Immunol Pract2023
36774155An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.Lancet2023
36737153Best of drug and vaccine allergy 2022.Ann Allergy Asthma Immunol2023
36563781Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice.J Allergy Clin Immunol Pract2023
34287942Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.Allergy2022
35398412Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy.J Allergy Clin Immunol2022
35497649The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.World Allergy Organ J2022
35717130We should not abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis.Ann Allergy Asthma Immunol2022
36434738Delayed onset urticaria and symptomatic dermographism following COVID-19 booster vaccination: A case series.Clin Transl Allergy2022
35964925Anaphylaxis after COVID-19 vaccination: A registry-based study.J Allergy Clin Immunol Pract2022
35960533Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain.J Clin Gastroenterol2022
35073571Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.Blood Adv2022
35325158Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine.J Infect Dis2022
35294816Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.N Engl J Med2022
34726142Symptom monitoring after coronavirus disease 2019 (COVID-19) vaccination in a large integrated healthcare system: Separating symptoms from severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection.Infect Control Hosp Epidemiol2022
34779000COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy.Allergy2022
30720546Allergic Reactions Captured by Voluntary Reporting.J Patient Saf2021
33657292Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.N Engl J Med2021
33685616Reply to "Penilloate and penicilloate concentrations in practical guidance recommendations".J Allergy Clin Immunol Pract2021
33793357Immediate reaction to ibrutinib amenable to oral desensitization.J Oncol Pharm Pract2021
33683290Acute Allergic Reactions to mRNA COVID-19 Vaccines.JAMA2021
33866033COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.J Allergy Clin Immunol Pract2021
33781932Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential.Ann Allergy Asthma Immunol2021
33892171The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.J Allergy Clin Immunol Pract2021
33838846Reply to "PEG skin testing for COVID-19 allergy".J Allergy Clin Immunol Pract2021
33603408Optimal Management of Hereditary Angioedema: Shared Decision-Making.J Asthma Allergy2021
34698847Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.JAMA Netw Open2021
34627541Reply to "Isosulfan blue-induced perioperative systemic allergic reactions".J Allergy Clin Immunol Pract2021
34125573Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.Ann Intern Med2021
33980329Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.Allergy Asthma Proc2021
33980328Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden.Allergy Asthma Proc2021
33980327Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.Allergy Asthma Proc2021
33980326Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.Allergy Asthma Proc2021
34166844First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.J Allergy Clin Immunol Pract2021
34309623Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.JAMA Intern Med2021
34166549Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.Clin Exp Allergy2021
34112481Reply to "How important is the second dose of the COVID-19 mRNA vaccine?".J Allergy Clin Immunol Pract2021
34048855Consensus on treatment goals in hereditary angioedema: A global Delphi initiative.J Allergy Clin Immunol2021
33258114Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.Allergy2021
  • 1 - 50 of 179

Recommended Authors

Tufts Medical Center
Career Start Year 2016
Number of shared co-authors 0
Yale University
Career Start Year 2015
Number of shared co-authors 0
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 2014
Number of shared co-authors 0
Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 1
Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 0
4Department of Pharmacy, Memphis Veterans Affairs Medical Center
Career Start Year 2011
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 2010
Number of shared co-authors 5
Loyola University
Career Start Year 2010
Number of shared co-authors 0
University of Maryland School of Medicine
Career Start Year 2009
Number of shared co-authors 4
Rush University Medical Center
Career Start Year 2008
Number of shared co-authors 4
University of Notre Dame
Career Start Year 2008
Number of shared co-authors 2
Department of Pharmacy, Massachusetts General Hospital
Career Start Year 2007
Number of shared co-authors 3
Children's Mercy Hospitals and Clinics
Career Start Year 2004
Number of shared co-authors 2
Universite Libre de Bruxelles (ULB)
Career Start Year 2003
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 2
Ann Robert H Lurie Children's Hospital of Chicago
Career Start Year 1991
Number of shared co-authors 4
VA San Diego Healthcare System Mission Valley Clinic
Career Start Year 1991
Number of shared co-authors 0
Southern Medical University
Career Start Year 1990
Number of shared co-authors 1
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 0
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1986
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 2
Johns Hopkins School of Medicine
Career Start Year 1981
Number of shared co-authors 5
Career Start Year 1979
Number of shared co-authors 0
Scripps Clinic
Career Start Year 1977
Number of shared co-authors 3
Feinberg School of Medicine, Northwestern University
Career Start Year 1977
Number of shared co-authors 0
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 1

Collaborators

University of California San Diego
Co-authored papers 45
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 36
Allergy and Asthma Research Associates Research Center
Co-authored papers 28
University of Cincinnati College of Medicine, and Bernstein Clinical Research Center
Co-authored papers 27
Icahn School of Medicine at Mount Sinai
Co-authored papers 22
Penn State University
Co-authored papers 20
University of California San Diego
Co-authored papers 19
Massachusetts General Hospital
Co-authored papers 11
Vanderbilt University Medical Center
Co-authored papers 11
Vanderbilt University Medical Center, Vanderbilt University
Co-authored papers 8
Mayo Clinic College of Medicine and Science
Co-authored papers 2
University of Texas Southwestern Medical Center
Co-authored papers 2
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Co-authored papers 1
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Co-authored papers 1
Duke University
Co-authored papers 1
University of Cincinnati College of Medicine
Co-authored papers 1
Wake Forest School of Medicine
Co-authored papers 1
SUNY-Downstate Medical Center/Kings County Hospital Center
Co-authored papers 1
Co-authored papers 1
and Clinical Center (GRECC), Tennessee Valley Healthcare System
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Henry Ford Hospital System
Co-authored papers 1
American College of Emergency Physicians
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
University of Michigan School of Medicine ann arbor
Co-authored papers 1
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Co-authored papers 1